- BNF:
- 8.1.2
- Status:
- Red
- Decision Date:
- March 2014
Comments
RED:1,2,3 NICE TA306: Monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkins B-cell lymphoma
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again